RB1CC1 and neoplasm: Specifically, RB1CC1 has been associated with migration and invasion ability in HCC, and RB1CC1-related signaling pathways sensitized tumor cells to ferroptosis, demonstrating that targeting RB1CC1 could promote the treatment of HCC (61, 62).